Estrella Immunopharma (ESLA) Short Interest Ratio & Short Volume $1.14 +0.06 (+5.09%) As of 04:00 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Estrella Immunopharma Short Interest DataEstrella Immunopharma (ESLA) has a short interest of 1,900 shares, representing 0.02% of the float (the number of shares available for trading by the public). This marks a -88.82% decrease in short interest from the previous month. The short interest ratio (days to cover) is 0.0, indicating that it would take 0.0 days of the average trading volume of 84,399 shares to cover all short positions.Current Short Interest1,900 sharesPrevious Short Interest17,000 sharesChange Vs. Previous Month-88.82%Dollar Volume Sold Short$1,616.90Short Interest Ratio0.0 Days to CoverLast Record DateApril 15, 2025Outstanding Shares36,166,000 sharesFloat Size10,100,000 sharesShort Percent of Float0.02%Today's Trading Volume1,654 sharesAverage Trading Volume84,399 sharesToday's Volume Vs. Average2% Short Selling Estrella Immunopharma? Sign up to receive the latest short interest report for Estrella Immunopharma and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartESLA Short Interest Over TimeESLA Days to Cover Over TimeESLA Percentage of Float Shorted Over Time Estrella Immunopharma Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/15/20251,900 shares $1,616.90 -88.8%0.0%0 $0.85 3/31/202517,000 shares $15,759.00 -24.8%0.2%0.3 $0.93 3/15/202522,600 shares $20,792.00 +2.7%0.2%0.4 $0.92 2/28/202522,000 shares $22,660.00 +349.0%0.2%0.3 $1.03 2/15/20254,900 shares $5,978.00 -52.9%0.1%0.1 $1.22 1/31/202510,400 shares $10,930.40 -28.3%0.1%0.4 $1.05 1/15/202514,500 shares $16,670.65 +17.9%0.1%0.5 $1.15 12/31/202412,300 shares $14,760.00 -10.9%0.1%0.3 $1.20 12/15/202413,800 shares $16,473.06 -63.4%0.1%0.1 $1.19 11/30/202437,700 shares $42,789.50 +158.2%0.4%0.3 $1.14 Get the Latest News and Ratings for ESLA and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Estrella Immunopharma and its competitors with MarketBeat's FREE daily newsletter. 11/15/202414,600 shares $12,994.00 +124.6%0.1%0.1 $0.89 10/31/20246,500 shares $5,199.35 -57.0%0.1%0.1 $0.80 10/15/202415,100 shares $12,231.00 -95.6%0.2%0.1 $0.81 9/30/2024346,200 shares $401,592.00 +3,506.3%3.9%1.8 $1.16 9/15/20249,600 shares $10,464.00 -51.3%0.1%0.1 $1.09 8/31/202419,700 shares $24,822.00 -1.5%0.2%0.2 $1.26 8/15/202420,000 shares $28,200.00 -50.0%0.2%0.2 $1.41 7/31/202440,000 shares $62,400.00 +109.4%0.4%0.4 $1.56 7/15/202419,100 shares $28,650.00 +8.5%0.2%1.1 $1.50 6/30/202417,600 shares $18,480.00 +60.0%0.2%1.2 $1.05 6/15/202411,000 shares $10,340.00 +0.9%0.1%0.8 $0.94 5/31/202410,900 shares $10,320.12 +18.5%0.1%0.5 $0.95 5/15/20249,200 shares $9,936.00 -18.6%0.1%0.3 $1.08 4/30/202411,300 shares $11,865.00 +145.7%0.1%0.4 $1.05 4/15/20244,600 shares $4,876.00 -41.8%0.1%0.2 $1.06 3/31/20247,900 shares $9,796.00 +61.2%0.1%0.2 $1.24 3/15/20244,900 shares $5,439.00 -88.1%0.1%0.1 $1.11 2/29/202441,100 shares $41,922.00 -28.0%0.5%1 $1.02 2/15/202457,100 shares $62,239.00 +117.9%0.7%1.2 $1.09 1/31/202426,200 shares $29,344.00 No Change0.3%0.5 $1.12 ESLA Short Interest - Frequently Asked Questions What is Estrella Immunopharma's current short interest? Short interest is the volume of Estrella Immunopharma shares that have been sold short but have not yet been closed out or covered. As of April 15th, traders have sold 1,900 shares of ESLA short. 0.02% of Estrella Immunopharma's shares are currently sold short. Learn More on Estrella Immunopharma's current short interest. What is a good short interest percentage for Estrella Immunopharma? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.02% of Estrella Immunopharma's floating shares are currently sold short. Is Estrella Immunopharma's short interest increasing or decreasing? Estrella Immunopharma saw a drop in short interest during the month of April. As of April 15th, there was short interest totaling 1,900 shares, a drop of 88.8% from the previous total of 17,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Estrella Immunopharma's float size? Estrella Immunopharma currently has issued a total of 36,166,000 shares. Some of Estrella Immunopharma's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Estrella Immunopharma currently has a public float of 10,100,000 shares. How does Estrella Immunopharma's short interest compare to its competitors? 0.02% of Estrella Immunopharma's shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Estrella Immunopharma: Theratechnologies Inc. (10.63%), SELLAS Life Sciences Group, Inc. (11.17%), Enanta Pharmaceuticals, Inc. (14.13%), Editas Medicine, Inc. (15.65%), Procaps Group S.A. (0.12%), Neumora Therapeutics, Inc. (20.67%), Lexeo Therapeutics, Inc. (11.76%), Instil Bio, Inc. (16.45%), Senti Biosciences, Inc. (0.88%), RAPT Therapeutics, Inc. (12.25%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Invesco QQQ ($21.71 billion), iShares 20+ Year Treasury Bond ETF ($9.48 billion), Strategy Incorporated ($8.92 billion), Charter Communications, Inc. ($3.86 billion), Apollo Global Management, Inc. ($3.86 billion), Capital One Financial Co. ($3.72 billion), Super Micro Computer, Inc. ($3.47 billion), AppLovin Co. ($2.64 billion), VanEck Semiconductor ETF ($2.46 billion), and The Kroger Co. ($2.33 billion). View all of the most shorted stocks. What does it mean to sell short Estrella Immunopharma stock? Short selling ESLA is an investing strategy that aims to generate trading profit from Estrella Immunopharma as its price is falling. ESLA shares are trading down $0.02 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Estrella Immunopharma? A short squeeze for Estrella Immunopharma occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of ESLA, which in turn drives the price of the stock up even further. How often is Estrella Immunopharma's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including ESLA, twice per month. The most recent reporting period available is April, 15 2025. More Short Interest Resources from MarketBeat Related Companies Theratechnologies Short Interest Data SELLAS Life Sciences Group Short Interest Data Enanta Pharmaceuticals Short Interest Data Editas Medicine Short Interest Data Procaps Group Short Interest Data Neumora Therapeutics Short Interest Data Lexeo Therapeutics Short Interest Data Instil Bio Short Interest Data Senti Biosciences Short Interest Data RAPT Therapeutics Short Interest Data Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:ESLA) was last updated on 5/1/2025 by MarketBeat.com Staff From Our PartnersBlackrock’s Sending THIS Crypto Higher on PurposeWhile everyone's distracted by Bitcoin's moves, a stealth revolution is underway. One altcoin is quietly po...Crypto 101 Media | SponsoredHow to invest in Elon Musk’s Optimus before its launchElon Musk is set to completely take over the AI industry with Optimus… A breakthrough AI-powered robot that El...InvestorPlace | SponsoredElon Set to Shock the World by May 1st ?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | SponsoredTrump announcement boosts “next Bitcoin”President Trump just made his first big crypto move ... Announcing the creation of a national strategic re...Weiss Ratings | SponsoredThis Is How Empires FallThe headlines scream tariffs and export bans — but the real damage is happening in retirement portfolios. Tim ...Investors Alley | SponsoredIs he more powerful than Trump? Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredTrump and Buffett Are Quietly Leading America’s Gold RevivalThe “Buffett Indicator” Predicts Gold Set To Dominate for Next Decade Each time the Buffett Indicator has...Golden Portfolio | SponsoredElon’s Terrifying Warning Forces Trump To Take ActionElon Musk has avoided two major financial crises before. He pulled Tesla and SpaceX back from the brink of col...American Hartford Gold | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Estrella Immunopharma, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Estrella Immunopharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.